EMPAVELI Injector

About Enable Injections

Enable Injections is a private, commercial-stage medical device company focused on redefining drug delivery for biologics and other high-volume therapies. Its flagship enFuse® wearable platform allows for the subcutaneous administration of large-volume drugs, offering patients greater freedom and convenience compared to traditional IV administration. The company has established key partnerships with pharmaceutical firms like Incyte and Sanofi, has a commercially approved product for Empaveli, and is actively expanding its manufacturing and global regulatory footprint. Enable operates at the intersection of drug delivery and biologics, providing a platform technology to pharmaceutical partners.

Other Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs